Donor-derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantation

Autor: J Hows, K Beddow, E Gordon-Smith, DR Branch, W Spruce, I Sniecinski, RA Krance, LD Petz

Publikováno v: Blood. 67:177-181

Six cases of immune hemolytic anemia attributed to donor-derived red cell antibodies after allogeneic bone marrow transplantation (BMT) are reported. In 2/6 cases, severe intravascular hemolysis was seen, 6/6 required increased red cell transfusion,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b6bf4b0cd2798acb23e15eea2ff65ed9
https://doi.org/10.1182/blood.v67.1.177.bloodjournal671177

Two distinct categories of warm autoantibody reactivity with age-fractionated red cells

Autor: DR Branch, IA Shulman, AL Sy Siok Hian, LD Petz

Publikováno v: Blood. 63(1)

Using age-fractionated erythrocytes, warm autoantibodies can be classified into two distinct categories, depending on their reactivity with reticulocyte-enriched (younger) or reticulocyte-poor (older) red cell fractions. The strength of the direct an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93f075944f9b28743248357d3782dfc4
https://pubmed.ncbi.nlm.nih.gov/6418230

Recognition and control of neutrophil extracellular trap formation by MICL.

Autor: Malamud M; MRC Centre for Medical Mycology, University of Exeter, Exeter, UK., Whitehead L; Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK., McIntosh A; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK., Colella F; Centre for Arthritis and Musculoskeletal Health, University of Aberdeen, Aberdeen, UK., Roelofs AJ; Centre for Arthritis and Musculoskeletal Health, University of Aberdeen, Aberdeen, UK., Kusakabe T; Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York City, NY, USA.; The Jill Roberts Institute for Research in Inflammatory Bowel Disease (JRI), Weill Cornell Medicine, New York City, NY, USA., Dambuza IM; MRC Centre for Medical Mycology, University of Exeter, Exeter, UK.; Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK., Phillips-Brookes A; MRC Centre for Medical Mycology, University of Exeter, Exeter, UK., Salazar F; MRC Centre for Medical Mycology, University of Exeter, Exeter, UK., Perez F; Program in Cell Biology, Hospital for Sick Children, Toronto, Ontario, Canada., Shoesmith R; MRC Centre for Medical Mycology, University of Exeter, Exeter, UK., Zakrzewski P; School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Sey EA; MRC Centre for Medical Mycology, University of Exeter, Exeter, UK., Rodrigues C; MRC Centre for Medical Mycology, University of Exeter, Exeter, UK., Morvay PL; MRC Centre for Medical Mycology, University of Exeter, Exeter, UK.; Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK., Redelinghuys P; Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK., Bedekovic T; MRC Centre for Medical Mycology, University of Exeter, Exeter, UK., Fernandes MJG; Faculty of Medicine, Department of Microbiology, Infectious Diseases, and Immunology, Laval University, Quebec City, Quebec, Canada., Almizraq R; Medical Affairs and Innovation, Canadian Blood Services, Toronto, Ontario, Canada., Branch DR; Medical Affairs and Innovation, Canadian Blood Services, Toronto, Ontario, Canada., Amulic B; School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Harvey J; MRC Centre for Medical Mycology, University of Exeter, Exeter, UK., Stewart D; Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK., Yuecel R; Centre for Cytomics, University of Exeter, Exeter, UK., Reid DM; Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK., McConnachie A; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK., Pickering MC; Department of Immunology and Inflammation, Imperial College London, London, UK., Botto M; Department of Immunology and Inflammation, Imperial College London, London, UK., Iliev ID; Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York City, NY, USA.; The Jill Roberts Institute for Research in Inflammatory Bowel Disease (JRI), Weill Cornell Medicine, New York City, NY, USA., McInnes IB; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK., De Bari C; Centre for Arthritis and Musculoskeletal Health, University of Aberdeen, Aberdeen, UK., Willment JA; MRC Centre for Medical Mycology, University of Exeter, Exeter, UK.; Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK., Brown GD; MRC Centre for Medical Mycology, University of Exeter, Exeter, UK. gordon.brown@exeter.ac.uk.; Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK. gordon.brown@exeter.ac.uk.

Publikováno v: Nature [Nature] 2024 Sep; Vol. 633 (8029), pp. 442-450. Date of Electronic Publication: 2024 Aug 14.

Oncolytic Virus Senecavirus A Inhibits Hepatocellular Carcinoma Proliferation and Growth by Inducing Cell Cycle Arrest and Apoptosis.

Autor: Gong T; Department of Clinical Medicine, North Sichuan Medical College, Nanchong, Sichuan, China.; Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, Sichuan, China., Liu X; College of Animal Science and Technology, Southwest University, Chongqing, China., Li Q; Department of Clinical Medicine, North Sichuan Medical College, Nanchong, Sichuan, China.; Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, Sichuan, China., Branch DR; Departments of Medicine and Laboratory Medicine and Pathobiology, Centre for Innovation, Canadian Blood Services, Hamilton, Ontario, Canada., Loriamini M; Departments of Medicine and Laboratory Medicine and Pathobiology, Centre for Innovation, Canadian Blood Services, Hamilton, Ontario, Canada., Wen W; Department of Clinical Medicine, North Sichuan Medical College, Nanchong, Sichuan, China.; Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, Sichuan, China., Shi Y; Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, Sichuan, China., Tan Q; Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, Sichuan, China., Fan B; Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, Sichuan, China., Zhou Z; Department of Clinical Medicine, North Sichuan Medical College, Nanchong, Sichuan, China., Li Y; Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, Sichuan, China., Yang C; Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, Sichuan, China., Li S; Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, Sichuan, China., Duan X; Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, Sichuan, China., Chen L; Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, Sichuan, China.; The Hospital of Xidian Group, Xi'an, Shaanxi, China.; The Joint-Laboratory on Transfusion-Transmitted Diseases (TTDs) between Institute of Blood Transfusion and Nanning Blood Center, Nanning Blood Center, Nanning, Guangxi, China.

Publikováno v: Journal of clinical and translational hepatology [J Clin Transl Hepatol] 2024 Aug 28; Vol. 12 (8), pp. 713-725. Date of Electronic Publication: 2024 Jun 20.

Correction: An activator of G protein-coupled receptor and MEK1/2-ERK1/2 signaling inhibits HIV-1 replication by altering viral RNA processing.

Autor: Wong RW, Balachandran A, Cheung PK, Cheng R, Pan Q, Stoilov P, Harrigan PR, Blencowe BJ, Branch DR, Cochrane A

Publikováno v: PLoS pathogens [PLoS Pathog] 2024 Apr 09; Vol. 20 (4), pp. e1012155. Date of Electronic Publication: 2024 Apr 09 (Print Publication: 2024).